Back to search
Leukemia, Lymphoblastic, Acute
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Leukemia, Lymphoblastic, Acute trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Leukemia, Lymphoblastic, Acute trials you may qualify forBackground: Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy involves taking immune cells (T cells) from a…
Background: Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RAS genes. These mutations can cause the c…
The study is intended to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of AZD4512 in patients with relapsed/refractory B-Cel…
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat people with relapsed B-ALL. For those who ach…
This is a single-center, open-label, single-arm prospective study designed to evaluate the safety, tolerability, and efficacy of dual-target CD22/CD19 chimeric…
To evaluate, through a prospective multicenter observational study, autologous or allogeneic hematopoietic stem cell transplantation as consolidation therapy in…
This phase II clinical trial tests a chemotherapy regimen (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin with or without ri…